Robeco Institutional Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,096
Closed -$65K 957
2018
Q4
$65K Hold
1,096
﹤0.01% 933
2018
Q3
$127K Hold
1,096
﹤0.01% 933
2018
Q2
$138K Hold
1,096
﹤0.01% 922
2018
Q1
$119K Hold
1,096
﹤0.01% 907
2017
Q4
$120K Buy
1,096
+414
+61% +$41.3K ﹤0.01% 853
2017
Q3
$68K Sell
682
-11,650
-94% -$1.13M ﹤0.01% 830
2017
Q2
$1.25M Buy
+12,332
New +$1.33M 0.01% 636
2014
Q3
Sell
-2,346
Closed -$392K 766
2014
Q2
$392K Hold
2,346
﹤0.01% 629
2014
Q1
$465K Hold
2,346
﹤0.01% 581
2013
Q4
$448K Buy
2,346
+1,136
+94% +$211K ﹤0.01% 505
2013
Q3
$205K Hold
1,210
﹤0.01% 545
2013
Q2
$184K Buy
+1,210
New +$171K ﹤0.01% 532

Other funds holding CLB

Robeco Institutional Asset Management's CLB Position: Q1 2019 in Review

Robeco Institutional Asset Management sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 1,096 shares — an estimated $65K sold.

Robeco Institutional Asset Management first reported a position in CLB in Q2 2013 and held it in 12 quarters. The position peaked at $1.25M in Q2 2017. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

  • Robeco Institutional Asset Management reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 1,096 Core Laboratories shares in Q1 2019, an estimated $65K.
  • Robeco Institutional Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 12 quarters.
  • Robeco Institutional Asset Management's Core Laboratories position peaked at $1.25M in Q2 2017.
  • 313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on Robeco Institutional Asset Management's 13F filing for Q1 2019, filed 2 May 2019.